Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1995 May;73(5):422–427. doi: 10.1136/hrt.73.5.422

Comparison of five cardiac markers in the detection of reperfusion after thrombolysis in acute myocardial infarction.

F Lavin 1, M Kane 1, A Forde 1, F Gannon 1, K Daly 1
PMCID: PMC483857  PMID: 7786656

Abstract

OBJECTIVE--To investigate and compare the clinical usefulness of serial measurements of five cardiac marker proteins, namely creatine kinase (CK), CK-MB mass, myoglobin, troponin T, and myosin light chain 1, in the early detection of reperfusion after thrombolytic treatment. METHOD--Serial blood samples were taken from 26 patients presenting with acute myocardial infarction. Concentrations of the five markers were assayed in each sample. Thrombolytic treatment was given to the patients who were divided into those who reperfused (n = 17, group A) and those who failed to reperfuse (n = 9, group B) on the basis of clinical signs and angiography within 24 h. RESULTS--The release profiles of CK, CK-MB mass, myoglobin, and troponin T for patients in group A differed from those of patients in group B. No difference was observed in the release profile of myosin light chain 1 between the two groups. The time to peak concentration of CK, CK-MB mass, myoglobin, and troponin T occurred significantly earlier in patients of group A than in those of group B, with myoglobin peaking earlier than the other markers. An index, defined as the ratio of the concentration of each marker immediately before and 2 h after the start of thrombolytic treatment, was calculated for each marker in groups A and B. The 2 h myoglobin and troponin T indices were significantly different between groups A and B. The diagnostic efficiency of the myoglobin index, however, was best at 85%. CONCLUSIONS--These studies suggest that myoglobin has greater potential than the other markers examined in the detection of reperfusion after thrombolytic treatment.

Full text

PDF
422

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbottsmith C. W., Topol E. J., George B. S., Stack R. S., Kereiakes D. J., Candela R. J., Anderson L. C., Harrelson-Woodlief S. L., Califf R. M. Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty. J Am Coll Cardiol. 1990 Oct;16(4):770–778. doi: 10.1016/s0735-1097(10)80320-1. [DOI] [PubMed] [Google Scholar]
  2. Abe S., Arima S., Nomoto K., Maruyama I., Miyata M., Yamaguchi H., Okino H., Yamashita T., Atsuchi Y., Tahara M. Early detection of coronary reperfusion by rapid assessment of plasma myoglobin. Int J Cardiol. 1993 Jan;38(1):33–40. doi: 10.1016/0167-5273(93)90201-q. [DOI] [PubMed] [Google Scholar]
  3. Brandt D. R., Gates R. C., Eng K. K., Forsythe C. M., Korom G. K., Nitro A. S., Koffler P. A., Ogunro E. A. Quantifying the MB isoenzyme of creatine kinase with the Abbott "IMx" immunoassay analyzer. Clin Chem. 1990 Feb;36(2):375–378. [PubMed] [Google Scholar]
  4. Califf R. M., O'Neil W., Stack R. S., Aronson L., Mark D. B., Mantell S., George B. S., Candela R. J., Kereiakes D. J., Abbottsmith C. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. Ann Intern Med. 1988 May;108(5):658–662. doi: 10.7326/0003-4819-108-5-658. [DOI] [PubMed] [Google Scholar]
  5. Ellis A. K., Little T., Masud A. R., Liberman H. A., Morris D. C., Klocke F. J. Early noninvasive detection of successful reperfusion in patients with acute myocardial infarction. Circulation. 1988 Dec;78(6):1352–1357. doi: 10.1161/01.cir.78.6.1352. [DOI] [PubMed] [Google Scholar]
  6. Garabedian H. D., Gold H. K., Yasuda T., Johns J. A., Finkelstein D. M., Gaivin R. J., Cobbaert C., Leinbach R. C., Collen D. Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: correlation with acute angiography. J Am Coll Cardiol. 1988 Apr;11(4):729–734. doi: 10.1016/0735-1097(88)90204-5. [DOI] [PubMed] [Google Scholar]
  7. Gore J. M., Roberts R., Ball S. P., Montero A., Goldberg R. J., Dalen J. E. Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction. Am J Cardiol. 1987 Jun 1;59(15):1234–1238. doi: 10.1016/0002-9149(87)90896-4. [DOI] [PubMed] [Google Scholar]
  8. Guerci A. D., Gerstenblith G., Brinker J. A., Chandra N. C., Gottlieb S. O., Bahr R. D., Weiss J. L., Shapiro E. P., Flaherty J. T., Bush D. E. A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty. N Engl J Med. 1987 Dec 24;317(26):1613–1618. doi: 10.1056/NEJM198712243172601. [DOI] [PubMed] [Google Scholar]
  9. Hogg K. J., Hornung R. S., Howie C. A., Hockings N., Dunn F. G., Hillis W. S. Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute myocardial infarction: use of the ST segment as a non-invasive marker. Br Heart J. 1988 Oct;60(4):275–280. doi: 10.1136/hrt.60.4.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Katus H. A., Diederich K. W., Scheffold T., Uellner M., Schwarz F., Kübler W. Non-invasive assessment of infarct reperfusion: the predictive power of the time to peak value of myoglobin, CKMB, and CK in serum. Eur Heart J. 1988 Jun;9(6):619–624. doi: 10.1093/oxfordjournals.eurheartj.a062551. [DOI] [PubMed] [Google Scholar]
  11. Katus H. A., Diederich K. W., Schwarz F., Uellner M., Scheffold T., Kübler W. Influence of reperfusion on serum concentrations of cytosolic creatine kinase and structural myosin light chains in acute myocardial infarction. Am J Cardiol. 1987 Sep 1;60(7):440–445. doi: 10.1016/0002-9149(87)90282-7. [DOI] [PubMed] [Google Scholar]
  12. Kircher B. J., Topol E. J., O'Neill W. W., Pitt B. Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy. Am J Cardiol. 1987 Mar 1;59(6):513–515. doi: 10.1016/0002-9149(87)91158-1. [DOI] [PubMed] [Google Scholar]
  13. Mair J., Artner-Dworzak E., Lechleitner P., Morass B., Smidt J., Wagner I., Dienstl F., Puschendorf B. Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin. Br Heart J. 1992 Nov;68(5):462–468. doi: 10.1136/hrt.68.11.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Norris R. M., White H. D., Cross D. B., Woo K. S., Elliott J. M., Twigden D., Williams B., Johnson R. N. Non-invasive diagnosis of arterial patency after thrombolytic treatment and its relation to prognosis. Br Heart J. 1993 Jun;69(6):485–491. doi: 10.1136/hrt.69.6.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schiøler V., Thode J., Kjøller E. Performance characteristics of creatine kinase-MB isoenzyme measured with an immunoenzymometric and an immunoinhibition assay in acute myocardial infarction with and without thrombolytic therapy. Eur J Clin Chem Clin Biochem. 1992 Jun;30(6):357–361. doi: 10.1515/cclm.1992.30.6.357. [DOI] [PubMed] [Google Scholar]
  16. Simoons M. L., Serruys P. W., van den Brand M., Res J., Verheugt F. W., Krauss X. H., Remme W. J., Bär F., de Zwaan C., van der Laarse A. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cardiol. 1986 Apr;7(4):717–728. doi: 10.1016/s0735-1097(86)80329-1. [DOI] [PubMed] [Google Scholar]
  17. Topol E. J., Califf R. M., George B. S., Kereiakes D. J., Abbottsmith C. W., Candela R. J., Lee K. L., Pitt B., Stack R. S., O'Neill W. W. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 1987 Sep 3;317(10):581–588. doi: 10.1056/NEJM198709033171001. [DOI] [PubMed] [Google Scholar]
  18. Van de Werf F., Arnold A. E. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction. BMJ. 1988 Nov 26;297(6660):1374–1379. doi: 10.1136/bmj.297.6660.1374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Verstraete M., Bernard R., Bory M., Brower R. W., Collen D., de Bono D. P., Erbel R., Huhmann W., Lennane R. J., Lubsen J. Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator. Lancet. 1985 Apr 13;1(8433):842–847. doi: 10.1016/s0140-6736(85)92208-1. [DOI] [PubMed] [Google Scholar]
  20. White H. D., Norris R. M., Brown M. A., Takayama M., Maslowski A., Bass N. M., Ormiston J. A., Whitlock T. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med. 1987 Oct 1;317(14):850–855. doi: 10.1056/NEJM198710013171402. [DOI] [PubMed] [Google Scholar]
  21. Wilcox R. G., von der Lippe G., Olsson C. G., Jensen G., Skene A. M., Hampton J. R. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet. 1988 Sep 3;2(8610):525–530. doi: 10.1016/s0140-6736(88)92656-6. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES